You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

Stroke and Stroke Rehabilitation: Anticoagulant Therapy Prescribed for Atrial Fibrillation at Discharge

Percentage of patients aged 18 years and older with a diagnosis of ischemic stroke or transient ischemic attack (TIA) with documented permanent, persistent, or paroxysmal atrial fibrillation who were prescribed an anticoagulant at discharge

Date Reviewed: April 7, 2014

Measure Info

NQF 0241CMS 033NQF Endorsement Removed
Measure Type: 
Measure Steward: 
American Academy of Neurology
Clinical Topic Area: 

Care Setting: 
Data Source: 
Electronic Health Records

Atrial fibrillation is a significant modifiable risk factor for stroke. Preventive treatment lessens the chance of subsequent events and their attendant costs, morbidity, and mortality. The measure aligns clinicians’ practice with the goals of high value care by its focus on low-cost prevention of potentially expensive sequelae. We note that the measure would be improved by a clear enumeration of the medical reasons for withholding treatment. Reasons related to risk (for example, risk of fall) should require documentation of evaluation.